Shao et al. reported, in a retrospective study of 68 rectal cancer patients treated with neoadjuvant RT, that tumor cells PD-L1+ was significantly correlated to short-course RT, suggesting that PD-L1 expression might be regulated by modifying the RT scheme [35]. Here, CD274 is linked to rectal cancer.